Shares of Dr. Reddy’s Laboratories Limited rose over 7% on Thursday, April 23, trading against the broader market trend during the session.
The stock opened at ₹1,230.00 against its previous close of ₹1,217.00, touching a session high of ₹1,304.80 and a low of ₹1,217.50. The 52-week range stands between ₹1,129.40 and ₹1,379.70.
Dr. Reddy’s Laboratories Limited is a Hyderabad-based pharmaceutical company engaged in the manufacture and sale of generic medicines, active pharmaceutical ingredients, and proprietary products across India and international markets including the United States, Europe, and emerging markets.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.